General Information of Drug (ID: DM4WUEP)

Drug Name
U-54494A Drug Info
Synonyms
C18H24Cl2N2O; U 54494A; U 54494; U-54494; U-54494A; cis-3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)benzamide; Benzamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-; AC1L3TTM; 92953-41-8; AC1Q3O5Y; SCHEMBL11610023; 3,4-dichloro-n-methyl-n-[(1r,2r)-2-(pyrrolidin-1-yl)cyclohexyl]benzamide; LS-178194; A845921; UNII-I3NE36R0XJ component JUBNVWGVNWIXMB-IAGOWNOFSA-N; trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzamide
Cross-matching ID
PubChem CID
122015
CAS Number
CAS 92953-41-8
TTD Drug ID
D0B7HJ

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Amoebiasis -1.69 3.79e-2 99/102 (97.06%) COL1A2;PRKCB;LAMC2;...
Pentose and glucuronate interconversions -1.72 2.70e-2 17/34 (50%) UGT2B4;KL;DCXR;...
Pertussis -1.74 2.57e-2 64/76 (84.21%) TICAM1;IRAK1;IL1B;...
Renin-angiotensin system -1.75 2.61e-2 20/23 (86.96%) MME;KLK2;AGT;...
Ferroptosis -1.80 1.17e-2 36/41 (87.8%) GCLM;TFRC;SLC39A14;...
Proteasome -1.80 1.18e-2 44/46 (95.65%) PSMB6;PSMD12;PSMB10;...
TNF signaling pathway -1.82 9.29e-3 103/112 (91.96%) CASP10;RELA;RIPK1;...
Mineral absorption -1.86 7.59e-3 48/60 (80%) MT2A;ATP1B1;MT1G;...
Legionellosis -1.87 7.08e-3 51/57 (89.47%) SAR1A;CASP7;NFKB2;...
Steroid biosynthesis -1.89 8.50e-3 19/20 (95%) CYP51A1;NSDHL;HSD17B7;...
Complement and coagulation cascades -1.91 1.06e-2 76/85 (89.41%) F7;F9;SERPINC1;...
NF-kappa B signaling pathway -1.93 1.06e-2 90/104 (86.54%) VCAM1;NFKB1;BTK;...
Porphyrin and chlorophyll metabolism -2.04 0.00e+0 23/43 (53.49%) COX15;CPOX;GUSB;...
Hematopoietic cell lineage -2.06 0.00e+0 90/99 (90.91%) CD33;CD36;IL1B;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 10uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 10uM 6H, 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 10uM 6H, 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 10uM 6H, 24H